Highly sensitive liquid chromatography–electrospray mass spectrometry (LC–MS) method for the determination of etoposide levels in human serum and plasma

This publication has 21 references indexed in Scilit:

• State-of-the-art in liquid chromatography–mass spectrometry
  Journal of Chromatography A, 1999
• Bioavailability of Etoposide after Oral Administration of the Solution Marketed for Intravenous Use: Therapeutic and Pharmacoeconomic Perspectives
  Archives of Medical Research, 1999
• Determination of unbound etoposide concentration in ultrafiltered plasma by high-performance liquid chromatography with fluorimetric detection
  Journal of Chromatography B: Biomedical Sciences and Applications, 1996
• High-performance liquid chromatography with fluorometric detection for monitoring of etoposide and its cis-isomer in plasma and leukaemic cells
  Journal of Chromatography B: Biomedical Sciences and Applications, 1995
• An ELISA for the measurement of VP16 (etoposide) in unextracted plasma
  Journal of Immunological Methods, 1988
• The Clinical Pharmacology of Etoposide and Teniposide
  Clinical Pharmacokinetics, 1987
• Combined thin layer chromatography/mass spectrometry: An application of252Cf plasma desorption mass spectrometry for drug monitoring
  Journal of Mass Spectrometry, 1985
• High-Performance Liquid Chromatographic Analysis of the Semisynthetic Epipodophyllotoxins Teniposide and Etoposide Using Electrochemical Detection
  Journal of Pharmaceutical Sciences, 1984
• Analysis of the anticancer drugs etoposide (VP 16-213) and teniposide (VM 26) by high-performance liquid chromatography with fluorescence detection
  Journal of Chromatography B: Biomedical Sciences and Applications, 1981
• Analysis of the anticancer drugs VP 16-213 and VM 26 and their metabolites by high-performance liquid chromatography
  Journal of Chromatography B: Biomedical Sciences and Applications, 1980